{"id":688,"date":"2022-06-08T10:38:47","date_gmt":"2022-06-08T17:38:47","guid":{"rendered":"https:\/\/merlinglobal.flywheelsites.com\/us\/?page_id=688"},"modified":"2024-04-30T10:42:49","modified_gmt":"2024-04-30T17:42:49","slug":"news-press","status":"publish","type":"page","link":"https:\/\/merlinmelanomatest.com\/us\/news-press\/","title":{"rendered":"News &#038; Press"},"content":{"rendered":"<p><div id=\"press-releases\" class=\"fusion-container-anchor\"><div class=\"fusion-fullwidth fullwidth-box fusion-builder-row-1 fusion-flex-container has-pattern-background has-mask-background nonhundred-percent-fullwidth non-hundred-percent-height-scrolling press-releases\" style=\"--awb-border-radius-top-left:0px;--awb-border-radius-top-right:0px;--awb-border-radius-bottom-right:0px;--awb-border-radius-bottom-left:0px;--awb-padding-top:80px;--awb-padding-bottom:80px;--awb-padding-bottom-medium:0px;--awb-flex-wrap:wrap;\" ><div class=\"fusion-builder-row fusion-row fusion-flex-align-items-flex-start fusion-flex-content-wrap\" style=\"max-width:1248px;margin-left: calc(-4% \/ 2 );margin-right: calc(-4% \/ 2 );\"><div class=\"fusion-layout-column fusion_builder_column fusion-builder-column-0 fusion_builder_column_1_1 1_1 fusion-flex-column\" style=\"--awb-bg-size:cover;--awb-width-large:100%;--awb-margin-top-large:0px;--awb-spacing-right-large:1.92%;--awb-margin-bottom-large:20px;--awb-spacing-left-large:1.92%;--awb-width-medium:100%;--awb-spacing-right-medium:1.92%;--awb-spacing-left-medium:1.92%;--awb-width-small:100%;--awb-spacing-right-small:1.92%;--awb-spacing-left-small:1.92%;\"><div class=\"fusion-column-wrapper fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-1 fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;\"><div class=\"title-sep-container title-sep-container-left fusion-no-large-visibility fusion-no-medium-visibility fusion-no-small-visibility\"><div class=\"title-sep sep-single sep-solid\" style=\"border-color:#e2e2e2;\"><\/div><\/div><span class=\"awb-title-spacer fusion-no-large-visibility fusion-no-medium-visibility fusion-no-small-visibility\"><\/span><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;--fontSize:40;line-height:1.2;\">Press Releases<\/h2><span class=\"awb-title-spacer\"><\/span><div class=\"title-sep-container title-sep-container-right\"><div class=\"title-sep sep-single sep-solid\" style=\"border-color:#e2e2e2;\"><\/div><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;width:100%;\"><\/div><div class=\"fusion-post-cards fusion-post-cards-1 fusion-grid-archive fusion-grid-columns-1\" style=\"--awb-column-spacing:0px;--awb-dots-align:center;--awb-columns:1;--awb-active-filter-border-size:3px;--awb-filters-height:36px;--awb-columns-medium:100%;--awb-columns-small:100%;\" data-post-type-label=\"press releases\"><ul class=\"fusion-grid fusion-grid-1 fusion-flex-align-items-flex-start fusion-grid-posts-cards fusion-grid-container-infinite\" data-pages=\"3\"><li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-1 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-2 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/wp-content\/uploads\/sites\/2\/2026\/03\/FC-SDX-0167-1226-Melanoma-SkylineDx.pdf\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">NCCN Clinical Guidelines in Oncology (NCCN Guidelines\u00ae) Melanoma: Cutaneous &#8211; Version 1.2026 SkylineDx 2-Page Flashcard<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-1 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Mar 24, 2026<\/p>\n<\/div><div class=\"fusion-title title fusion-title-3 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/wp-content\/uploads\/sites\/2\/2026\/03\/FC-SDX-0167-1226-Melanoma-SkylineDx.pdf\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-2 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-4 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-that-cp-gep-merlin-cp-gep-is-now-recognized-by-the-nccn-clinical-practice-guidelines-in-oncology-nccn-guidelines-as-a-predictive-gep-test-that-may-be-used-in-select-cutan\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Announces that CP-GEP (Merlin CP-GEP) is Now Recognized by the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) as a Predictive GEP Test That May be Used in Select Cutaneous Melanoma Patients to Assess Metastatic Risk<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-2 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Feb 19, 2026<\/p>\n<\/div><div class=\"fusion-title title fusion-title-5 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-that-cp-gep-merlin-cp-gep-is-now-recognized-by-the-nccn-clinical-practice-guidelines-in-oncology-nccn-guidelines-as-a-predictive-gep-test-that-may-be-used-in-select-cutan\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-3 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-6 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-publishes-landmark-merlin_001-trial-in-jama-surgery-validating-the-predictive-power-of-the-merlin-cp-gep-test-in-melanoma\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-3 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Oct 22, 2025<\/p>\n<\/div><div class=\"fusion-title title fusion-title-7 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-publishes-landmark-merlin_001-trial-in-jama-surgery-validating-the-predictive-power-of-the-merlin-cp-gep-test-in-melanoma\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-4 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-8 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedxs-merlin-melanoma-assay-shows-its-ability-to-reduce-slnb-by-over-40-in-a-danish-multicenter-validation-study\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx\u2019s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-4 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Jul 22, 2025<\/p>\n<\/div><div class=\"fusion-title title fusion-title-9 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedxs-merlin-melanoma-assay-shows-its-ability-to-reduce-slnb-by-over-40-in-a-danish-multicenter-validation-study\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-5 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-10 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-presents-landmark-findings-from-the-largest-prospective-multicenter-melanoma-gep-trial-at-sso-2025\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Presents Landmark Findings from the Largest Prospective Multicenter Melanoma GEP trial at SSO 2025<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-5 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Mar 28, 2025<\/p>\n<\/div><div class=\"fusion-title title fusion-title-11 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-presents-landmark-findings-from-the-largest-prospective-multicenter-melanoma-gep-trial-at-sso-2025\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-12 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/independent-meta-analyses-by-melanoma-institute-of-australia-on-cp-gep-model-in-melanoma-care\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Independent meta-analyses by Melanoma Institute of Australia on CP-GEP model in Melanoma Care<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-6 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Oct 25, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-13 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/independent-meta-analyses-by-melanoma-institute-of-australia-on-cp-gep-model-in-melanoma-care\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-7 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-14 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-late-breaking-data-presentation-from-the-largest-prospective-multi-center-melanoma-gene-expression-profiling-trial-at-the-21st-international-congress-of-the-society-for-melanoma-re\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Announces Late-Breaking Data Presentation from The Largest Prospective Multi-Center Melanoma Gene Expression Profiling Trial at The 21st International Congress of the Society for Melanoma Research<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-7 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Oct 13, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-15 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-late-breaking-data-presentation-from-the-largest-prospective-multi-center-melanoma-gene-expression-profiling-trial-at-the-21st-international-congress-of-the-society-for-melanoma-re\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-8 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-16 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-presentation-of-new-data-highlighting-the-predictive-power-of-the-cp-gep-merlin-test-for-t1a-cutaneous-melanoma-patients-at-the-21st-international-congress-of-the-society-for-melan\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Announces Presentation of New Data Highlighting the Predictive Power of the CP-GEP Merlin Test for T1a Cutaneous Melanoma Patients at the 21st International Congress of the Society for Melanoma Research<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-8 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Oct 11, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-17 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-presentation-of-new-data-highlighting-the-predictive-power-of-the-cp-gep-merlin-test-for-t1a-cutaneous-melanoma-patients-at-the-21st-international-congress-of-the-society-for-melan\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-9 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-18 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-upcoming-oral-presentation-at-the-21st-international-congress-of-the-society-for-melanoma-research\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Announces Upcoming Oral Presentation at the 21st International Congress of the Society for Melanoma Research<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-9 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Oct 8, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-19 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-upcoming-oral-presentation-at-the-21st-international-congress-of-the-society-for-melanoma-research\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-10 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-20 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-all-patients-enrolled-in-landmark-study-merlin_001-advancing-melanoma-diagnostics\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Announces All Patients Enrolled in Landmark Study MERLIN_001, Advancing Melanoma Diagnostics<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-10 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Jul 9, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-21 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-all-patients-enrolled-in-landmark-study-merlin_001-advancing-melanoma-diagnostics\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-11 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-22 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedxs-merlin-assay-stratifies-stage-i-ii-cutaneous-melanoma-beyond-slnb-for-recurrence\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx\u2019s Merlin Assay stratifies Stage I\/II cutaneous melanoma beyond SLNB for recurrence<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-11 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>May 30, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-23 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedxs-merlin-assay-stratifies-stage-i-ii-cutaneous-melanoma-beyond-slnb-for-recurrence\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-12 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-24 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/independent-european-data-on-cp-gep-model-in-stratifying-melanoma-patients-for-long-term-survival\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Independent European data on CP-GEP model in Stratifying Melanoma Patients for Long Term Survival<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-12 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Apr 5, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-25 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/independent-european-data-on-cp-gep-model-in-stratifying-melanoma-patients-for-long-term-survival\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-13 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-26 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/independent-validation-of-performance-merlin-test-in-swedish-patients\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Independent validation of performance Merlin Test in Swedish patients<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-13 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Mar 24, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-27 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/independent-validation-of-performance-merlin-test-in-swedish-patients\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-14 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-28 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/melanoma-risk-prediction-of-nodal-metastasis-and-long-term-survival-outcome-by-cp-gep-model-in-a-u-s-cohort\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Melanoma risk prediction of nodal metastasis and long-term survival outcome by CP-GEP model in a U.S. cohort<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-14 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Mar 8, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-29 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/melanoma-risk-prediction-of-nodal-metastasis-and-long-term-survival-outcome-by-cp-gep-model-in-a-u-s-cohort\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<li class=\"fusion-layout-column fusion_builder_column fusion-builder-column-15 fusion-flex-column news-press-release-post-card post-card fusion-grid-column fusion-post-cards-grid-column\" style=\"--awb-bg-blend:overlay;--awb-bg-size:cover;--awb-flex-grow:0;--awb-flex-shrink:0;--awb-flex-grow-medium:0;--awb-flex-shrink-medium:0;--awb-flex-grow-small:0;--awb-flex-shrink-small:0;\"><div class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"><div class=\"fusion-title title fusion-title-30 fusion-sep-none fusion-title-text fusion-title-size-two\" style=\"--awb-margin-top-small:10px;--awb-margin-right-small:0px;--awb-margin-bottom-small:10px;--awb-margin-left-small:0px;--awb-link-color:var(--awb-custom14);--awb-font-size:24px;\"><h2 class=\"fusion-title-heading title-heading-left fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:24;--minFontSize:24;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-grant-of-european-patent-and-advances-in-melanoma-diagnosis-and-treatment\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">SkylineDx Announces Grant of European Patent and Advances in Melanoma Diagnosis and Treatment<\/a><\/h2><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:20px;margin-bottom:0px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><div class=\"fusion-text fusion-text-15 fusion-text-no-margin post-meta\" style=\"--awb-font-size:14px;--awb-line-height:1.2;--awb-margin-top:8px;--awb-margin-bottom:8px;\"><p>Jan 9, 2024<\/p>\n<\/div><div class=\"fusion-title title fusion-title-31 fusion-sep-none fusion-title-text fusion-title-size-div fusion-read-more\" style=\"--awb-margin-top:8px;--awb-margin-bottom:8px;--awb-margin-top-small:8px;--awb-margin-right-small:0px;--awb-margin-bottom-small:8px;--awb-margin-left-small:0px;--awb-margin-top-medium:8px;--awb-margin-bottom-medium:8px;--awb-font-size:14px;\"><div class=\"fusion-title-heading title-heading-right title-heading-tag fusion-responsive-typography-calculated\" style=\"margin:0;font-size:1em;--fontSize:14;--minFontSize:14;line-height:1.2;\"><a href=\"https:\/\/merlinmelanomatest.com\/us\/press_release\/skylinedx-announces-grant-of-european-patent-and-advances-in-melanoma-diagnosis-and-treatment\/\" class=\"awb-custom-text-color awb-custom-text-hover-color\" target=\"_self\">Read More<\/a><\/div><\/div><div class=\"fusion-separator fusion-full-width-sep\" style=\"align-self: center;margin-left: auto;margin-right: auto;margin-top:0px;margin-bottom:20px;width:100%;\"><div class=\"fusion-separator-border sep-single sep-solid\" style=\"--awb-height:20px;--awb-amount:20px;border-color:#e2e2e2;border-top-width:1px;\"><\/div><\/div><\/div><\/li>\n<\/ul><div class=\"fusion-infinite-scroll-trigger\"><\/div><div class=\"pagination infinite-scroll clearfix\" style=\"display:none;\"><span class=\"current\">1<\/span><a href=\"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/688\/page\/2\/\" class=\"inactive\">2<\/a><a class=\"pagination-next\" rel=\"next\" href=\"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/688\/page\/2\/\"><span class=\"page-text\">Next<\/span><span class=\"page-next\"><\/span><\/a><\/div><div class=\"fusion-clearfix\"><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-688","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News &amp; Press - Merlin US<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/merlinmelanomatest.com\/us\/news-press\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News &amp; Press - Merlin US\" \/>\n<meta property=\"og:url\" content=\"https:\/\/merlinmelanomatest.com\/us\/news-press\/\" \/>\n<meta property=\"og:site_name\" content=\"Merlin US\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-30T17:42:49+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/news-press\\\/\",\"url\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/news-press\\\/\",\"name\":\"News & Press - Merlin US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/#website\"},\"datePublished\":\"2022-06-08T17:38:47+00:00\",\"dateModified\":\"2024-04-30T17:42:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/news-press\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/news-press\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/news-press\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News &#038; Press\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/#website\",\"url\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/\",\"name\":\"Merlin US\",\"description\":\"A powerful tool in personalized melanoma care\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/merlinmelanomatest.com\\\/us\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"News & Press - Merlin US","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/merlinmelanomatest.com\/us\/news-press\/","og_locale":"en_US","og_type":"article","og_title":"News & Press - Merlin US","og_url":"https:\/\/merlinmelanomatest.com\/us\/news-press\/","og_site_name":"Merlin US","article_modified_time":"2024-04-30T17:42:49+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/merlinmelanomatest.com\/us\/news-press\/","url":"https:\/\/merlinmelanomatest.com\/us\/news-press\/","name":"News & Press - Merlin US","isPartOf":{"@id":"https:\/\/merlinmelanomatest.com\/us\/#website"},"datePublished":"2022-06-08T17:38:47+00:00","dateModified":"2024-04-30T17:42:49+00:00","breadcrumb":{"@id":"https:\/\/merlinmelanomatest.com\/us\/news-press\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/merlinmelanomatest.com\/us\/news-press\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/merlinmelanomatest.com\/us\/news-press\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/merlinmelanomatest.com\/us\/"},{"@type":"ListItem","position":2,"name":"News &#038; Press"}]},{"@type":"WebSite","@id":"https:\/\/merlinmelanomatest.com\/us\/#website","url":"https:\/\/merlinmelanomatest.com\/us\/","name":"Merlin US","description":"A powerful tool in personalized melanoma care","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/merlinmelanomatest.com\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/688","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/comments?post=688"}],"version-history":[{"count":10,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/688\/revisions"}],"predecessor-version":[{"id":1443,"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/pages\/688\/revisions\/1443"}],"wp:attachment":[{"href":"https:\/\/merlinmelanomatest.com\/us\/wp-json\/wp\/v2\/media?parent=688"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}